Clinical Trial Update: A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating multiple doses of sisunatovir in individuals with respiratory syncytial virus infection. The update indicates the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Sisunatovir (Sisunatovir)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED